Stux Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$4.55M Sell
93,800
-15,900
-14% -$784K 0.59% 36
2014
Q1
$5.7M Buy
109,700
+62,500
+132% +$3.33M 0.7% 31
2013
Q4
$2.51M Sell
47,200
-9,300
-16% -$474K 0.3% 106
2013
Q3
$2.62M Buy
56,500
+3,700
+7% +$162K 0.35% 89
2013
Q2
$2.36M Buy
+52,800
New +$2.29M 0.3% 100

Other funds holding BMY

Stux Capital Management's BMY Position: Q2 2014 in Review

Stux Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2014, selling an estimated $784K and leaving 93,800 shares worth $4.55M. The position accounts for 0.59% of the portfolio, ranked #36.

Stux Capital Management first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $5.7M in Q1 2014. 1,303 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Stux Capital Management held 93,800 shares of Bristol-Myers Squibb worth $4.55M as of Q2 2014.
  • Stux Capital Management sold 15,900 Bristol-Myers Squibb shares in Q2 2014, an estimated $784K.
  • Bristol-Myers Squibb made up 0.59% of Stux Capital Management's portfolio in Q2 2014, its #36 holding.
  • Stux Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
  • Stux Capital Management's Bristol-Myers Squibb position peaked at $5.7M in Q1 2014.
  • 1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.